162 related articles for article (PubMed ID: 32308063)
1. Advances in HIV diagnosis and monitoring.
Kabir MA; Zilouchian H; Caputi M; Asghar W
Crit Rev Biotechnol; 2020 Aug; 40(5):623-638. PubMed ID: 32308063
[TBL] [Abstract][Full Text] [Related]
2. Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less.
Bélec L; Bonn JP
Future Microbiol; 2011 Nov; 6(11):1251-60. PubMed ID: 22082287
[TBL] [Abstract][Full Text] [Related]
3. Emerging technologies for point-of-care management of HIV infection.
Shafiee H; Wang S; Inci F; Toy M; Henrich TJ; Kuritzkes DR; Demirci U
Annu Rev Med; 2015; 66():387-405. PubMed ID: 25423597
[TBL] [Abstract][Full Text] [Related]
4. Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring.
Lifson MA; Ozen MO; Inci F; Wang S; Inan H; Baday M; Henrich TJ; Demirci U
Adv Drug Deliv Rev; 2016 Aug; 103():90-104. PubMed ID: 27262924
[TBL] [Abstract][Full Text] [Related]
5. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
6. Can HIV reverse transcriptase activity assay be a low-cost alternative for viral load monitoring in resource-limited settings?
Gupta S; Palchaudhuri R; Neogi U; Srinivasa H; Ashorn P; De Costa A; Källander C; Shet A
BMJ Open; 2016 Jan; 6(1):e008795. PubMed ID: 26817634
[TBL] [Abstract][Full Text] [Related]
7. Modelling response to HIV therapy without a genotype: an argument for viral load monitoring in resource-limited settings.
Revell AD; Wang D; Harrigan R; Hamers RL; Wensing AM; Dewolf F; Nelson M; Geretti AM; Larder BA
J Antimicrob Chemother; 2010 Apr; 65(4):605-7. PubMed ID: 20154024
[TBL] [Abstract][Full Text] [Related]
8. A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral therapy.
Newman H; Breunig L; van Zyl G; Stich A; Preiser W
J Clin Virol; 2014 Aug; 60(4):387-91. PubMed ID: 24929754
[TBL] [Abstract][Full Text] [Related]
9. Point of Care Diagnostics for HIV in Resource Limited Settings: An Overview.
Manoto SL; Lugongolo M; Govender U; Mthunzi-Kufa P
Medicina (Kaunas); 2018 Mar; 54(1):. PubMed ID: 30344234
[TBL] [Abstract][Full Text] [Related]
10. Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.
Svärd J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sönnerborg A
PLoS One; 2017; 12(6):e0178942. PubMed ID: 28582463
[TBL] [Abstract][Full Text] [Related]
11. Detection of acute HIV infection: we can't close the window.
Branson BM; Stekler JD
J Infect Dis; 2012 Feb; 205(4):521-4. PubMed ID: 22207652
[No Abstract] [Full Text] [Related]
12. Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges.
Roberts T; Cohn J; Bonner K; Hargreaves S
Clin Infect Dis; 2016 Apr; 62(8):1043-8. PubMed ID: 26743094
[TBL] [Abstract][Full Text] [Related]
13. HIV type 1 drug resistance in adults receiving highly active antiretroviral therapy in Abidjan, Côte d'Ivoire.
Hanson DL; Adjé-Touré C; Talla-Nzussouo N; Eby P; Borget MY; Kouadio LY; Celestin BE; Tossou O; Eholie S; Kadio A; Chorba T; Nkengasong JN
AIDS Res Hum Retroviruses; 2009 May; 25(5):489-95. PubMed ID: 19388820
[TBL] [Abstract][Full Text] [Related]
14. The Evolving Landscape of HIV Drug Resistance Diagnostics for Expanding Testing in Resource-Limited Settings.
Inzaule SC; Hamers RL; Paredes R; Yang C; Schuurman R; Rinke de Wit TF
AIDS Rev; 2017; 19(4):219-230. PubMed ID: 28182618
[TBL] [Abstract][Full Text] [Related]
15. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
16. Developments in CD4 and viral load monitoring in resource-limited settings.
Rowley CF
Clin Infect Dis; 2014 Feb; 58(3):407-12. PubMed ID: 24218101
[TBL] [Abstract][Full Text] [Related]
17. New developments in laboratory monitoring of HIV-1 infection.
Telenti A
Clin Microbiol Infect; 2002 Mar; 8(3):137-43. PubMed ID: 12010168
[TBL] [Abstract][Full Text] [Related]
18. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
19. The measurement of HIV-1 viral load in resource-limited settings: how and where?
Rouet F; Rouzioux C
Clin Lab; 2007; 53(3-4):135-48. PubMed ID: 17447649
[TBL] [Abstract][Full Text] [Related]
20. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update January 2007)].
;
Enferm Infecc Microbiol Clin; 2007 Jan; 25(1):32-53. PubMed ID: 17261244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
